These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


75 related items for PubMed ID: 2170005

  • 21. Suramin inhibits the growth of non-small-cell lung cancer cells that express the epidermal growth factor receptor.
    Fujiuchi S, Ohsaki Y, Kikuchi K.
    Oncology; 1997; 54(2):134-40. PubMed ID: 9075785
    [Abstract] [Full Text] [Related]

  • 22. Phosphoinositide kinase, diacylglycerol kinase, and phospholipase C activities associated to the cytoskeleton: effect of epidermal growth factor.
    Payrastre B, van Bergen en Henegouwen PM, Breton M, den Hartigh JC, Plantavid M, Verkleij AJ, Boonstra J.
    J Cell Biol; 1991 Oct; 115(1):121-8. PubMed ID: 1655800
    [Abstract] [Full Text] [Related]

  • 23. Phosphatidylinositol 4-kinases and the role of polyphosphoinositides in cellular regulation.
    Pike LJ.
    Endocr Rev; 1992 Nov; 13(4):692-706. PubMed ID: 1333947
    [Abstract] [Full Text] [Related]

  • 24. Comparative effects of epidermal growth factor and carbachol on phosphoinositide synthesis and breakdown in pancreatic acinar cells.
    Conway BR, Laychock SG, Rubin RP.
    Biochem Biophys Res Commun; 1991 Jul 31; 178(2):780-5. PubMed ID: 1650199
    [Abstract] [Full Text] [Related]

  • 25. Disruption of cellular energy balance by suramin in intact human prostatic carcinoma cells, a likely antiproliferative mechanism.
    Rago R, Mitchen J, Cheng AL, Oberley T, Wilding G.
    Cancer Res; 1991 Dec 15; 51(24):6629-35. PubMed ID: 1742736
    [Abstract] [Full Text] [Related]

  • 26. Epidermal growth factor stimulates diacylglycerol kinase in isolated plasma membrane vesicles from A431 cells.
    Kato M, Homma Y, Nagai Y, Takenawa T.
    Biochem Biophys Res Commun; 1985 Jun 14; 129(2):375-80. PubMed ID: 2990452
    [Abstract] [Full Text] [Related]

  • 27. Autocrine secretion of a colorectum-derived growth factor by HT-29 human colon carcinoma cell line.
    Culouscou JM, Garrouste F, Remacle-Bonnet M, Bettetini D, Marvaldi J, Pommier G.
    Int J Cancer; 1988 Dec 15; 42(6):895-901. PubMed ID: 3263953
    [Abstract] [Full Text] [Related]

  • 28. Mitogenic action of lysophosphatidic acid and phosphatidic acid on fibroblasts. Dependence on acyl-chain length and inhibition by suramin.
    van Corven EJ, van Rijswijk A, Jalink K, van der Bend RL, van Blitterswijk WJ, Moolenaar WH.
    Biochem J; 1992 Jan 01; 281 ( Pt 1)(Pt 1):163-9. PubMed ID: 1731751
    [Abstract] [Full Text] [Related]

  • 29. Arachidonoyl-diacylglycerol kinase. Specific in vitro inhibition by polyphosphoinositides suggests a mechanism for regulation of phosphatidylinositol biosynthesis.
    Walsh JP, Suen R, Glomset JA.
    J Biol Chem; 1995 Dec 01; 270(48):28647-53. PubMed ID: 7499383
    [Abstract] [Full Text] [Related]

  • 30. Suramin inhibits growth factor binding and proliferation by urothelial carcinoma cell cultures.
    Gansler T, Vaghmar N, Olson JJ, Graham SD.
    J Urol; 1992 Sep 01; 148(3):910-4. PubMed ID: 1512858
    [Abstract] [Full Text] [Related]

  • 31. The effect of schedule, protein binding and growth factors on the activity of suramin.
    Lopez Lopez R, Peters GJ, van Loenen AC, Pizao PE, van Rijswijk RE, Wagstaff J, Pinedo HM.
    Int J Cancer; 1992 Jul 30; 51(6):921-6. PubMed ID: 1639540
    [Abstract] [Full Text] [Related]

  • 32. Pleiotropic actions of suramin on the proliferation of human breast-cancer cells in vitro.
    Foekens JA, Sieuwerts AM, Stuurman-Smeets EM, Dorssers LC, Berns EM, Klijn JG.
    Int J Cancer; 1992 May 28; 51(3):439-44. PubMed ID: 1592534
    [Abstract] [Full Text] [Related]

  • 33. Carbachol stimulates a different phospholipid metabolism than nerve growth factor and basic fibroblast growth factor in PC12 cells.
    Pessin MS, Altin JG, Jarpe M, Tansley F, Bradshaw RA, Raben DM.
    Cell Regul; 1991 May 28; 2(5):383-90. PubMed ID: 1892912
    [Abstract] [Full Text] [Related]

  • 34. Evidence for the presence of phosphoinositide cycle and its involvement in cellular signal transduction in the rabbit lens.
    Vivekanandan S, Lou MF.
    Curr Eye Res; 1989 Jan 28; 8(1):101-11. PubMed ID: 2539949
    [Abstract] [Full Text] [Related]

  • 35. Evidence for a carbachol stimulated phosphatidylinositol effect in heart.
    Quist EE.
    Biochem Pharmacol; 1982 Oct 01; 31(19):3130-33. PubMed ID: 7150339
    [Abstract] [Full Text] [Related]

  • 36. Muscarinic stimulation of phospholipid turnover in dissociated avian salt gland cells.
    Fisher SK, Hootman SR, Heacock AM, Ernst SA, Agranoff BW.
    FEBS Lett; 1983 May 02; 155(1):43-6. PubMed ID: 6840282
    [Abstract] [Full Text] [Related]

  • 37. Suramin modulates cellular levels of hepatocyte growth factor receptor by inducing shedding of a soluble form.
    Galvani AP, Cristiani C, Carpinelli P, Landonio A, Bertolero F.
    Biochem Pharmacol; 1995 Sep 28; 50(7):959-66. PubMed ID: 7575680
    [Abstract] [Full Text] [Related]

  • 38. Phosphoinositide kinases.
    Fruman DA, Meyers RE, Cantley LC.
    Annu Rev Biochem; 1998 Sep 28; 67():481-507. PubMed ID: 9759495
    [Abstract] [Full Text] [Related]

  • 39. A product of phosphatidylinositol-3 kinase is elevated in dividing HT29 colonic epithelial cells.
    Dobos GJ, Wu XR, Traynor-Kaplan A.
    FEBS Lett; 1993 Jun 14; 324(2):143-6. PubMed ID: 8389720
    [Abstract] [Full Text] [Related]

  • 40. Inhibitory effect of suramin on receptor binding and cytotoxic activity of tumor necrosis factor alpha.
    Grazioli L, Alzani R, Ciomei M, Mariani M, Restivo A, Cozzi E, Marcucci F.
    Int J Immunopharmacol; 1992 May 14; 14(4):637-42. PubMed ID: 1325955
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 4.